These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14982907)

  • 41. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
    Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Magnesium sulphate: an improvement in the field of preterm infant neuroprotection].
    Marret S
    Gynecol Obstet Fertil; 2010 Feb; 38(2):81-2. PubMed ID: 20117034
    [No Abstract]   [Full Text] [Related]  

  • 43. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants.
    Doyle L; Crowther C; Middleton P; Voysey M; Marret S; Rouse D
    BJOG; 2011 Jun; 118(7):891-2; author reply 892-3. PubMed ID: 21564486
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines.
    Zeng X; Xue Y; Tian Q; Sun R; An R
    Medicine (Baltimore); 2016 Jan; 95(1):e2451. PubMed ID: 26735551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
    Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
    JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antenatal magnesium sulfate: Neuro-protection for preterm infants.
    Oddie S; Tuffnell DJ; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2015 Nov; 100(6):F553-7. PubMed ID: 25896966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Obstet Gynecol; 2009 Jun; 113(6):1327-1333. PubMed ID: 19461430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A report from #BlueJC: are we convinced antenatal magnesium sulphate can prevent cerebral palsy in preterm infants?
    Berggren EK; Leung EY
    BJOG; 2014 Apr; 121(5):647. PubMed ID: 24636319
    [No Abstract]   [Full Text] [Related]  

  • 50. Magnesium sulfate for the prevention of cerebral palsy.
    Mittendorf R; Pryde PG
    N Engl J Med; 2009 Jan; 360(2):189-90; author reply 190. PubMed ID: 19129535
    [No Abstract]   [Full Text] [Related]  

  • 51. MgSO4 for CP prevention: too good to be true?
    Macones GA
    Am J Obstet Gynecol; 2009 Jun; 200(6):589. PubMed ID: 19482111
    [No Abstract]   [Full Text] [Related]  

  • 52. Does antenatal magnesium sulfate prevent cerebral palsy in preterm infants? The final trial?
    Huusom LD; Brok J; Hegaard HK; Pryds O; Secher NJ
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1346-7. PubMed ID: 23016563
    [No Abstract]   [Full Text] [Related]  

  • 53. Antenatal magnesium sulfate to prevent cerebral palsy.
    Keir AK; Shepherd E; McIntyre S; Rumbold A; Groves C; Crowther C; Callander EJ
    Arch Dis Child Fetal Neonatal Ed; 2022 Mar; 107(2):225-227. PubMed ID: 34233908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The information gap between the required and the actual accrued information size in the meta-analysis of antenatal magnesium sulphate to prevent cerebral palsy in preterm infants.
    Wetterslev J; Imberger G
    BJOG; 2011 Jun; 118(7):890; author reply 891. PubMed ID: 21564485
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuroprotective approaches: before and after delivery.
    Chalak LF; Rouse DJ
    Clin Perinatol; 2011 Sep; 38(3):455-70. PubMed ID: 21890019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
    Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
    J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnesium sulfate, cerebral palsy prevention, and medical protocols.
    Repke JT
    Obstet Gynecol; 2013 Feb; 121(2 Pt 1):227-228. PubMed ID: 23344268
    [No Abstract]   [Full Text] [Related]  

  • 58. Magnesium sulfate and cerebral palsy in premature infants.
    Hirtz DG; Nelson K
    Curr Opin Pediatr; 1998 Apr; 10(2):131-7. PubMed ID: 9608889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [State of the use of magnesium sulfate for prevention of cerebral palsy in pre-term newborn in the Rouen's hospital].
    Millochau JC; Marret S; Oden S; Verspyck E
    Gynecol Obstet Fertil; 2016; 44(7-8):446-9. PubMed ID: 27426688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM;
    N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.